Cargando…
Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview
Mucositis is an inevitable side-effect of the conditioning regimens used for haematopoietic stem cell transplantation. The condition is better referred to as mucosal barrier injury (MBI) since it is primarily the result of toxicity and is a complex and dynamic pathobiological process manifested not...
Autores principales: | Blijlevens, NMA, Donnelly, JP, De Pauw, BE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091624/ https://www.ncbi.nlm.nih.gov/pubmed/10871732 http://dx.doi.org/10.1038/sj.bmt.1702447 |
Ejemplares similares
-
Long-Term Health Related Quality of Life following Intensive Care during Treatment for Haematological Malignancies
por: van Vliet, Maarten, et al.
Publicado: (2014) -
Overview of Histone Deacetylase Inhibitors in Haematological Malignancies
por: Bishton, Mark J., et al.
Publicado: (2010) -
(18)F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation
por: Vos, Fidel J., et al.
Publicado: (2011) -
Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies
por: van Rhee, K P, et al.
Publicado: (2022) -
Is intensive care beneficial for patients with haematologic malignancies?
por: Nyunga, M, et al.
Publicado: (2010)